J Hamanishi, N Takeshima, N Katsumata… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE This phase III, multicenter, randomized, open-label study investigated the
efficacy and safety of nivolumab versus chemotherapy (gemcitabine [GEM] or pegylated …